In this study, we examined the expression of MDR markers, specifically ABCB1, ABCC1, and ABCG2, in 17 patient-derived NSCLC cultures after exposure to 10 commonly prescribed TKIs for the treatment of NSCLC. The gene discussed is ABCB1; the disease is non-small cell lung carcinoma.